Chemoinformaics analysis of Isokhusinol oxide
| Molecular Weight | 236.355 | nRot | 1 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
| Exact Molecular Weight | 236.178 | nRing | 3 |
| Solubility: LogS | -2.647 | nHRing | 1 |
| Solubility: LogP | 2.74 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.657 |
| nHD | 1 | BPOL | 25.813 |
| QED | 0.561 |
| Synth | 4.679 |
| Natural Product Likeliness | 3.451 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.498 |
| MDCK | 0.0000292 |
| BBB | 0.981 |
| PPB | 0.659054 |
| VDSS | 1.602 |
| FU | 0.216301 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.292 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.907 |
| CYP2c9-inh | 0.046 |
| CYP2c9-sub | 0.132 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.524 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.492 |
| CL | 16.958 |
| T12 | 0.092 |
| hERG | 0.022 |
| Ames | 0.059 |
| ROA | 0.69 |
| SkinSen | 0.045 |
| Carcinogencity | 0.171 |
| EI | 0.024 |
| Respiratory | 0.877 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.899599 |